Treatment of venous thromboembolism: Adherence to guidelines and impact of physician knowledge, attitudes, and beliefs Joseph A. Caprini, MD, Victor F. Tapson, MD, Thomas M. Hyers, MD, Albert L. Waldo, MD, Ann K. Wittkowsky, PharmD, Richard Friedman, MD, Kevin J. Colgan, MA, Alicia C. Shillington, PhD Journal of Vascular Surgery Volume 42, Issue 4, Pages 726-733 (October 2005) DOI: 10.1016/j.jvs.2005.05.053 Copyright © 2005 The Society for Vascular Surgery Terms and Conditions
Fig 1 Discharge frequency by treatment for 907 patients with venous thromboembolism. Journal of Vascular Surgery 2005 42, 726-733DOI: (10.1016/j.jvs.2005.05.053) Copyright © 2005 The Society for Vascular Surgery Terms and Conditions
Fig 2 Length of stay by discharge treatment for 907 patients with venous thromboembolism. *Statistically significant difference in length of stay between injectable vs bridge (P < .01), injectable vs warfarin (P < .01), warfarin vs bridge (P < .001). Journal of Vascular Surgery 2005 42, 726-733DOI: (10.1016/j.jvs.2005.05.053) Copyright © 2005 The Society for Vascular Surgery Terms and Conditions